Evaluation of the usefulness of the measurement of plasma arginine vasopressin concentrations by LC-MS/MS method

Evaluation of the usefulness of the measurement of plasma arginine vasopressin concentrations by LC-MS/MS method - Evaluation of the usefulness of the measurement of plasma arginine vasopressin concentrations by LC-MS/MS method

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000043023

Enrollment

Registered

2021-06-01

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central diabetes insipidus, diencephalohypophysial diseases

Interventions

Hypertonic saline infusion test

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suspected to have central diabetes insipidus or diencephalohypophyseal diseases

Exclusion criteria

Exclusion criteria: Patients with hypernatremia (serum sodium concentration higher than or equal to 150 mEq/L)

Design outcomes

Primary

Measure	Time frame
Correlation between plasma vasopressin concentrations measured by radioimmunoassay and those measured by LC-MS/MS method.	—

Countries

Japan

Contacts

Public ContactDaisuke Hagiwara

Nagoya University Hospital Department of Endocrinology and Diabetes

d-hagiwarai@med.nagoya-u.ac.jp052-744-2142

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026